S-1: HeartCore Enterprises Secures $25M Equity Line, Addresses Nasdaq Listing Concerns Amid Significant Dilution

HeartCore Enterprises, a Tokyo-based software company, has entered into agreements for up to $25 million in equity financing and convertible preferred stock to bolster its growth initiatives and address critical Nasdaq listing deficiencies, though these actions will result in substantial shareholder dilution.

Summary

• HeartCore Enterprises, Inc. filed an S-1 registration statement for the resale of up to 60,556,785 shares of common stock by Crom Structured Opportunities Fund I, LP.
• The company is not selling shares in this offering but may receive up to $25,000,000 in gross proceeds from the Selling Stockholder under an Equity Purchase Agreement (EPA) dated June 30, 2025.
• The EPA allows the company to direct the Selling Stockholder to purchase common stock at 96% of the volume-weighted average price (VWAP) on the trading day preceding the advance notice, with a maximum commitment of $25,000,000.
• The Selling Stockholder also purchased 2,000 shares of Series A Convertible Preferred Stock for $2,000,000, convertible into common stock at 90% of the VWAP.
• As of July 21, 2025, the company had 23,310,770 shares of common stock outstanding; after the full issuance and conversion under these agreements, the outstanding shares could increase to 82,632,118, representing significant dilution.
• The company received notices from Nasdaq regarding non-compliance with the $1.00 minimum bid price requirement (on May 6, 2025, with a deadline of November 3, 2025) and the $2,500,000 minimum stockholders' equity requirement (on May 24, 2025, with an extension until September 30, 2025, contingent on completing the EPA and SPA transactions).
• HeartCore's business includes a Customer Experience (CX) division, a Digital Transformation (DX) division, and a 'GO IPO' consulting business for Japanese companies seeking U.S. listings, which has 16 active consulting agreements.
• Recent consulting agreements include a $500,000 fee and a 3% warrant from tmsuk Co. Ltd. (May 30, 2025) and a $500,000 fee and a 3% warrant from Cipher Core Co., Ltd. (June 30, 2025) for IPO assistance.
• An OEM Sales Agreement was signed with Silver Egg Technology CO. Ltd. on June 23, 2025, for AI recommendation services, with tiered monthly fees based on page views.
• Shareholders approved the issuance of shares exceeding 20% of outstanding common stock and a potential reverse stock split (1-for-2 to 1-for-30 ratio) on June 30, 2025, to address Nasdaq compliance.
• The company ceased to be a 'controlled company' in Q1 2025, leading to the formation of Compensation and Nominating and Corporate Governance Committees with independent directors.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to significant Nasdaq listing non-compliance issues (minimum bid price and stockholders' equity) and the substantial dilution resulting from the capital raise. While the company has secured funding and is actively addressing compliance, the risks associated with potential delisting and the dilutive nature of the financing weigh heavily on the outlook. The new business agreements offer some positive diversification but do not fully offset the immediate financial and listing challenges.

Positives

• Secured access to up to $25,000,000 in gross proceeds through an Equity Purchase Agreement, providing capital for software business growth initiatives.
• Successfully obtained stockholder approval for the issuance of shares exceeding 20% of outstanding common stock, facilitating the capital raise.
• Received an extension from Nasdaq until September 30, 2025, to regain compliance with the Minimum Stockholders' Equity Requirement, contingent on completing the capital raise transactions.
• Formed Compensation and Nominating and Corporate Governance Committees, comprised of independent directors, enhancing corporate governance following the change in 'controlled company' status.
• Expanded the 'GO IPO' consulting business with 16 active agreements, generating consulting fees ranging from $380,000 to $900,000 per company, plus warrants.
• Entered into new consulting agreements with tmsuk Co. Ltd. and Cipher Core Co., Ltd., each providing $500,000 in fees and a 3% warrant for IPO assistance.
• Signed an OEM Sales Agreement with Silver Egg Technology CO. Ltd. for AI recommendation services, expanding product offerings within the CX division.

Negatives

• Received a notice of non-compliance from Nasdaq on May 6, 2025, for failing to meet the $1.00 minimum bid price requirement, with a deadline of November 3, 2025, to regain compliance.
• Received a notice of non-compliance from Nasdaq on May 24, 2025, for failing to meet the $2,500,000 minimum stockholders' equity requirement, and does not meet alternative listing standards.
• The capital raise through the Equity Purchase Agreement and Series A Convertible Preferred Stock will result in substantial dilution to existing stockholders, increasing common shares outstanding from 23,310,770 to 82,632,118.
• The Selling Stockholder purchases common stock at a discount (96% of VWAP) and convertible preferred stock at a discount (90% of VWAP), which could lead to immediate resale and downward pressure on the stock price.
• The company has substantial indebtedness and may be unable to generate sufficient cash flow to satisfy debt service obligations, which could materially adversely affect its financial condition.
• The company is a holding company and depends on its subsidiary for cash flows, introducing a layer of financial risk.
• The company's management team will have broad discretion over the use of net proceeds from the capital raise, and investors may not agree with how the proceeds are utilized.

Risks

• The industry and markets are highly competitive, which could reduce market share and adversely affect business, financial position, results of operations, and cash flows.
• As a holding company, the company depends on its subsidiary for cash flows.
• Additional funding may be required for growth plans, potentially resulting in further dilution of investment.
• Payment of cash dividends from additional paid-in capital may expose the company to potential liabilities under state and federal fraudulent conveyance laws and legal distribution requirements.
• Highly concentrated voting power of capital stock may prevent minority stockholders from influencing significant corporate decisions and could result in conflicts of interest.
• Dependence on customer renewals, new customer additions, increased revenue from existing customers, and continued market growth for content management, customer experience management, task and process mining, and robotic process automation.
• Subscription renewal rates may decrease, harming future revenue and operating results.
• Quarterly fluctuations in operating results make future results difficult to predict and could cause results to fall below expectations or guidance.
• Substantial indebtedness could have important adverse consequences and adversely affect financial condition.
• Inability to generate sufficient cash flow to satisfy significant debt service obligations could have a material adverse effect on business, financial condition, and results of operations.
• Ability to incur substantially more debt, including off-balance sheet financing, contractual obligations, and general and commercial liabilities, could further exacerbate financial risks.
• It is not possible to predict the actual number of shares or gross proceeds from the Equity Purchase Agreement, as sales are at the company's discretion and depend on market conditions.
• The sale and issuance of common stock to the Selling Stockholder will cause dilution to existing stockholders, and the perception of such sales could cause the stock price to fall.
• Investors buying common stock from the Selling Stockholder at different times will likely pay different prices and may experience different levels of dilution and investment outcomes.
• The Selling Stockholder acquires common stock at a discount, and immediate resale could cause the stock price to decline, potentially leading to future investors not experiencing a similar rate of return.
• Management's broad discretion over the use of net proceeds from the capital raise means investors rely on their judgment, and proceeds may not be invested successfully.
• Failure to meet Nasdaq Capital Market continued listing requirements (minimum bid price, minimum stockholders' equity) could result in delisting, negatively affecting stock price, liquidity, and ability to obtain future financing.
• The exclusive forum provision and fee-shifting provision in the company's bylaws may limit stockholders' ability to bring certain claims or could result in significant costs if they do not prevail.

Future Outlook

The company plans to use the potential gross proceeds of up to $25,000,000 from the Equity Purchase Agreement to support software business growth initiatives. It intends to continue utilizing the exemption relating to a majority independent Board under Nasdaq's phase-in rules. The company is considering actions, including a potential reverse stock split, to regain compliance with Nasdaq's minimum bid price requirement. Future quarterly dividends are contingent upon Board approval and review of financial results, and may vary in amount.

Management Comments

• Our management team will have broad discretion over the use of the net proceeds from our sale of shares of our common stock to the Selling Stockholder, if any, and you may not agree with how we use the proceeds and the proceeds may not be invested successfully.
• We are currently monitoring the closing bid price of our common stock and evaluating our alternatives, if appropriate, to resolve the deficiency and regain compliance with this rule (Nasdaq minimum bid price).
• There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement, even if it maintains compliance with the other listing requirements.
• There can be no assurance that the Company will be able to regain compliance with the Minimum Stockholders Equity Requirement, even if it maintains compliance with the other listing requirements.

Industry Context

HeartCore Enterprises operates in the competitive software development industry, focusing on customer experience management (CX) and digital transformation (DX) solutions, including robotics process automation. Its 'GO IPO' business taps into the growing trend of Japanese companies seeking U.S. public listings, a niche market that leverages its expertise in U.S. GAAP conversion and SEC filing preparation. The OEM sales agreement for AI recommendation services aligns with the broader industry trend of integrating AI into customer engagement platforms.

Comparison to Industry Standards

• The company's Nasdaq listing non-compliance (minimum bid price of $1.00 and minimum stockholders' equity of $2,500,000) indicates a significant deviation from standard public company listing requirements, which could impact investor confidence and market liquidity.
• The capital raise structure, involving discounted share purchases by a single selling stockholder (Crom Structured Opportunities Fund I, LP) and substantial dilution (from 23.3M to 82.6M shares), is a common, albeit often dilutive, method for smaller companies to raise capital when traditional equity offerings are challenging, but it is not a best practice for maximizing shareholder value.
• The 10% per annum dividend on Series A Convertible Preferred Stock is a relatively high fixed return, reflecting the risk associated with preferred equity in a company facing listing challenges.
• The 'GO IPO' consulting business, with fees ranging from $380,000 to $900,000 plus warrants (1% to 4% fully-diluted share capital), appears to be a competitive offering for assisting foreign companies with complex U.S. listing processes, comparable to specialized boutique investment banks or legal/accounting firms in this niche.

Corporate Governance

Related Party Transactions

• Mr. Sumitaka Yamamoto, Chairman of Board, Chief Executive Officer and President, and a significant stockholder, established HeartCore Co. Ltd. (HeartCore Japan) in 2009, which is now a wholly owned subsidiary.

Stakeholder Impact

• **Shareholders**: Will experience significant dilution due to the issuance of up to 60,556,785 new shares, potentially reducing the value of their existing holdings. The potential reverse stock split will reduce the number of shares but not necessarily increase the aggregate market value of their holdings. The Nasdaq non-compliance poses a risk of delisting, which would negatively impact liquidity and share price.
• **Crom Structured Opportunities Fund I, LP (Selling Stockholder)**: Benefits from purchasing shares at a discount to market price and has the flexibility to resell shares, potentially realizing a positive rate of return. They also receive commitment shares as part of the agreements.
• **Company Management**: Gains broad discretion over the use of up to $25,000,000 in proceeds, which can be used to fund growth initiatives and address financial stability. They are also responsible for navigating Nasdaq compliance.
• **Employees**: The capital raise and efforts to maintain Nasdaq listing could provide stability and resources for business growth, potentially benefiting employees through continued employment and opportunities.
• **Customers**: The capital infusion is intended to support software business growth initiatives, which could lead to enhanced products and services for existing and future customers.
• **Nasdaq**: The company's actions are aimed at regaining compliance with Nasdaq listing rules, which is crucial for maintaining its public trading status and adhering to regulatory standards.

Next Steps

• The company must file an Information Statement on Schedule 14C and mail it to stockholders regarding the approved share issuances and potential reverse stock split; these actions will not become effective earlier than 20 calendar days after mailing.
• The company must have the ELOC Registration Statement declared effective by the SEC before issuing or selling any Advance Shares under the Equity Purchase Agreement (except for ELOC Commitment Shares).
• The company must have the registration statement for Conversion Shares and SPA Commitment Shares declared effective by the SEC within 90 days from June 30, 2025.
• The company needs to regain compliance with Nasdaq's $1.00 minimum bid price requirement by November 3, 2025, by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.
• The company must complete the transactions pursuant to the Equity Purchase Agreement and Securities Purchase Agreement and evidence compliance with the Nasdaq Minimum Stockholders' Equity Requirement by September 30, 2025.
• The company is considering actions, including a reverse stock split, to regain compliance with Nasdaq listing requirements.
• The company will continue to provide tmsuk Co. Ltd. with consulting services for 9 months, with potential extensions at an hourly rate.
• HeartCore Japan will continue to provide AI recommendation services under the OEM Sales Agreement with Silver Egg Technology CO. Ltd. for a two-year term, with automatic renewals.

Key Dates

Recommendation

The company is in a critical phase, actively addressing significant Nasdaq listing deficiencies (minimum bid price and stockholders' equity) through a substantial capital raise and a potential reverse stock split. While the secured funding of up to $25 million provides a lifeline for growth initiatives and compliance efforts, the associated dilution is severe, increasing outstanding shares by nearly 3.5 times. The discounted purchase price for the selling stockholder also creates immediate selling pressure. For a seasoned investor, the current situation presents high risk and uncertainty. A 'hold' recommendation is appropriate as the company is taking concrete steps to resolve its immediate challenges, but the outcome of these efforts, particularly regaining and maintaining Nasdaq compliance, remains uncertain. Investors should monitor the effectiveness of the capital deployment and the progress on Nasdaq compliance closely before considering further investment.

Keywords

Software Development, Customer Experience Management, Digital Transformation, Robotics Process Automation, Process Mining, Task Mining, IPO Consulting, Nasdaq Listing, Equity Financing, Convertible Preferred Stock, Share Dilution, Corporate Governance, SEC Filing, Japan, United States